Armata Pharmaceuticals (ARMP) EBITDA (2013 - 2026)
Armata Pharmaceuticals (ARMP) posted EBITDA of -$8.8 million for Q1 2026, up 36.45% sequentially from -$13.8 million in Q4 2025, and down 7.25% YoY from -$9.5 million in Q1 2025.
Armata Pharmaceuticals (ARMP) EBITDA (2013 - 2026) Analysis & Trends
Armata Pharmaceuticals has reported EBITDA for 14 years, with the latest figure at -$8.8 million in Q1 2026.
- Quarterly EBITDA fell 7.25% year-over-year to -$8.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$37.2 million (up 7.85% YoY) and the FY2025 annual result came in at -$36.6 million, up 13.67% from the prior year.
- EBITDA improved to -$8.8 million in Q1 2026 per ARMP's latest filing, from -$13.8 million in the prior quarter.
- Over five years, EBITDA peaked at -$6.8 million in Q2 2025 and troughed at -$13.8 million in Q4 2025.
- A 5-year average of -$9.7 million and a median of -$9.6 million in 2023 frame the typical range for EBITDA.
- The sharpest annual moves came in 2022 and 2025: EBITDA tumbled 70.77% in 2022, then surged 42.55% in 2025.
- Over 5 years, EBITDA stood at -$10.3 million in 2022, then advanced by 7.25% to -$9.6 million in 2023, then slipped by 10.02% to -$10.5 million in 2024, then plunged by 31.16% to -$13.8 million in 2025, then soared by 36.45% to -$8.8 million in 2026.
- According to Business Quant data, EBITDA over the past three periods registered -$8.8 million, -$13.8 million, and -$7.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 493.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -815.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 325.05 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 231.44 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -1.55 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 133.12 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -375.75 Mn |
| 10 | Armata Pharmaceuticals | 162.98 Mn | 138.98 Mn | - | -10.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -10.31 Mn |
| Mar 31, 2026 | -8.79 Mn |
| Dec 31, 2025 | -13.82 Mn |
| Sep 30, 2025 | -7.78 Mn |
| Jun 30, 2025 | -6.84 Mn |
| Mar 31, 2025 | -8.19 Mn |
| Dec 31, 2024 | -10.54 Mn |
| Sep 30, 2024 | -9.76 Mn |
| Jun 30, 2024 | -11.91 Mn |
| Mar 31, 2024 | -10.23 Mn |
| Dec 31, 2023 | -9.58 Mn |
| Sep 30, 2023 | -10.34 Mn |
| Jun 30, 2023 | -9.63 Mn |
| Mar 31, 2023 | -11.35 Mn |
| Dec 31, 2022 | -10.33 Mn |
| Sep 30, 2022 | -8.62 Mn |
| Jun 30, 2022 | -9.22 Mn |
| Mar 31, 2022 | -8.78 Mn |
| Dec 31, 2021 | -6.05 Mn |
| Sep 30, 2021 | -6.14 Mn |